169 related articles for article (PubMed ID: 19823752)
1. Characterization and development of novel small-molecules inhibiting GSK3 and activating Wnt signaling.
Zhong H; Zou H; Semenov MV; Moshinsky D; He X; Huang H; Li S; Quan J; Yang Z; Lin S
Mol Biosyst; 2009 Nov; 5(11):1356-60. PubMed ID: 19823752
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Wnt pathway in zebrafish as a screening method to identify novel therapeutic compounds.
Robertson JK; Danzmann K; Charles S; Blake K; Olivares A; Bamikole S; Olson M; Van Raay TJ
Exp Biol Med (Maywood); 2014 Feb; 239(2):169-76. PubMed ID: 24414478
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes.
Taelman VF; Dobrowolski R; Plouhinec JL; Fuentealba LC; Vorwald PP; Gumper I; Sabatini DD; De Robertis EM
Cell; 2010 Dec; 143(7):1136-48. PubMed ID: 21183076
[TBL] [Abstract][Full Text] [Related]
4. Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes.
Wagman AS; Johnson KW; Bussiere DE
Curr Pharm Des; 2004; 10(10):1105-37. PubMed ID: 15078145
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase 3 alpha and 3 beta have distinct functions during cardiogenesis of zebrafish embryo.
Lee HC; Tsai JN; Liao PY; Tsai WY; Lin KY; Chuang CC; Sun CK; Chang WC; Tsai HJ
BMC Dev Biol; 2007 Aug; 7():93. PubMed ID: 17683539
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase 3 has a proapoptotic function in Hydra gametogenesis.
Rentzsch F; Hobmayer B; Holstein TW
Dev Biol; 2005 Feb; 278(1):1-12. PubMed ID: 15649456
[TBL] [Abstract][Full Text] [Related]
7. Regulation of protein stability by GSK3 mediated phosphorylation.
Xu C; Kim NG; Gumbiner BM
Cell Cycle; 2009 Dec; 8(24):4032-9. PubMed ID: 19923896
[TBL] [Abstract][Full Text] [Related]
8. Polycyclic aromatic hydrocarbons and dibutyl phthalate disrupt dorsal-ventral axis determination via the Wnt/β-catenin signaling pathway in zebrafish embryos.
Fairbairn EA; Bonthius J; Cherr GN
Aquat Toxicol; 2012 Nov; 124-125():188-96. PubMed ID: 22975441
[TBL] [Abstract][Full Text] [Related]
9. A mutation in the Gsk3-binding domain of zebrafish Masterblind/Axin1 leads to a fate transformation of telencephalon and eyes to diencephalon.
Heisenberg CP; Houart C; Take-Uchi M; Rauch GJ; Young N; Coutinho P; Masai I; Caneparo L; Concha ML; Geisler R; Dale TC; Wilson SW; Stemple DL
Genes Dev; 2001 Jun; 15(11):1427-34. PubMed ID: 11390362
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-19b impairs cardiac development in zebrafish by targeting ctnnb1.
Li M; Hu X; Zhu J; Zhu C; Zhu S; Liu X; Xu J; Han S; Yu Z
Cell Physiol Biochem; 2014; 33(6):1988-2002. PubMed ID: 25034767
[TBL] [Abstract][Full Text] [Related]
11. Lithium chloride attenuates BMP-2 signaling and inhibits osteogenic differentiation through a novel WNT/GSK3- independent mechanism.
Li J; Khavandgar Z; Lin SH; Murshed M
Bone; 2011 Feb; 48(2):321-31. PubMed ID: 20932949
[TBL] [Abstract][Full Text] [Related]
12. Identification and regulation of glycogen synthase kinase-3 during bovine embryo development.
Aparicio IM; Garcia-Herreros M; Fair T; Lonergan P
Reproduction; 2010 Jul; 140(1):83-92. PubMed ID: 20427566
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase 3: more than a namesake.
Rayasam GV; Tulasi VK; Sodhi R; Davis JA; Ray A
Br J Pharmacol; 2009 Mar; 156(6):885-98. PubMed ID: 19366350
[TBL] [Abstract][Full Text] [Related]
14. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.
Bhat R; Xue Y; Berg S; Hellberg S; Ormö M; Nilsson Y; Radesäter AC; Jerning E; Markgren PO; Borgegård T; Nylöf M; Giménez-Cassina A; Hernández F; Lucas JJ; Díaz-Nido J; Avila J
J Biol Chem; 2003 Nov; 278(46):45937-45. PubMed ID: 12928438
[TBL] [Abstract][Full Text] [Related]
15. GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease.
Gao C; Hölscher C; Liu Y; Li L
Rev Neurosci; 2011 Dec; 23(1):1-11. PubMed ID: 22718609
[TBL] [Abstract][Full Text] [Related]
16. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
17. GSK3: a multifaceted kinase in Wnt signaling.
Wu D; Pan W
Trends Biochem Sci; 2010 Mar; 35(3):161-8. PubMed ID: 19884009
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling in hydroid development: ectopic heads and giant buds induced by GSK-3beta inhibitors.
Müller W; Frank U; Teo R; Mokady O; Guette C; Plickert G
Int J Dev Biol; 2007; 51(3):211-20. PubMed ID: 17486541
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6.
Wu G; Huang H; Garcia Abreu J; He X
PLoS One; 2009; 4(3):e4926. PubMed ID: 19293931
[TBL] [Abstract][Full Text] [Related]
20. GSK3 inhibitors regulate MYCN mRNA levels and reduce neuroblastoma cell viability through multiple mechanisms, including p53 and Wnt signaling.
Duffy DJ; Krstic A; Schwarzl T; Higgins DG; Kolch W
Mol Cancer Ther; 2014 Feb; 13(2):454-67. PubMed ID: 24282277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
